Health Care M&A Deals, December 25, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Gainwell Technologies’s acquisition of HMS for $3.4 billion. HMS provides a broad range of payment accuracy and population health management solutions, as well as analytics and engagement solutions. Gainwell Technologies, a portfolio company of Veritas Capital, is the former U.S. State and Local Health and Human Services business of DXC... Read More » Health Care M&A Deals, December 18, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AstraZeneca plc’s acquisition of Alexion Pharmaceuticals, Inc. for $39 billion. Alexion is a global biopharmaceutical company that has pioneered complement inhibition for a broad spectrum of immune-mediated rare diseases caused by uncontrolled activation of the complement system, a vital part of the immune system. Alexion’s expertise... Read More » Health Care M&A Deals, December 11, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Boehringer Ingelheim’s acquisition of NBE-Therapeutics for $1.429 billion from PPF Group. NBE-Therapeutics is a clinical-stage biotechnology company focused on antibody-drug conjugate (ADC) therapies for the treatment of solid tumors. NBE-Therapeutics’ lead compound NBE-002 is currently in Phase 1 clinical studies for triple negative breast... Read More » Health Care M&A Deals, December 4, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AdaptHealth Corp.’s (NASDAQ: AHCO) acquisition of AeroCare Holdings, Inc. for $2 billion from SkyKnight Capital. AeroCare Holdings is a home health distribution platform, providing service and equipment to patients with chronic respiratory conditions. Its network of over 260 locations across the U.S. provides service to more than 500,000... Read More »
The Biggest Healthcare Deals of 2020
Believe it or not, 2020 is over in just a few short weeks. Although most of our attention has been absorbed by the pandemic, the presidential election and an endless amount of Zoom calls at work, the healthcare M&A market managed to pull off some eye-catching surprises. The raw numbers and data might pale in comparison to that of 2019, but the activity is worth digging through. Early in December, there have been 1,374 deals announced, according to search results in our Healthcare Deal Database, a roughly 25% drop compared with the 1,841 deals on the books in 2019. Based on our monthly averages for the year, we might see somewhere between 100 and 120 more deals added by the end of... Read More »